From the Department of Neurology, Johns Hopkins Hospital, Baltimore, MD.
J ECT. 2019 Sep;35(3):212-214. doi: 10.1097/YCT.0000000000000573.
The aim of the study was to report a case of a patient who experienced a fatal aneurysmal subarachnoid hemorrhage during the course of electroconvulsive therapy (ECT).
This is a case report and review of the literature.
Electroconvulsive therapy is widely viewed as a safe and effective treatment for major depressive disorder; however, there remains some uncertainty regarding the safety of ECT in patients with cerebral aneurysms. Many cases exist documenting the safety of ECT in patients with both secured and unsecured cerebral aneurysms; however, these patients had aneurysms that were associated with a low (ie, ≤2.6%) 5-year cumulative rupture rate, whereas the patient in our case had an aneurysm associated with a 14.5% five-year cumulative rupture rate.
We stress that ECT should not be viewed as a universally safe procedure in patients with cerebral aneurysms and the 5-year cumulative aneurysm rupture rate should be used in the discussion of the risk-benefit ratio of ECT in patients with unsecured cerebral aneurysms.
本研究旨在报告一例在电抽搐治疗(ECT)过程中发生致命性蛛网膜下腔出血的患者。
这是一例病例报告,并对文献进行了回顾。
ECT 被广泛认为是治疗重度抑郁症的一种安全有效的方法;然而,在伴有脑动脉瘤的患者中,ECT 的安全性仍存在一些不确定性。许多病例证明了 ECT 在伴有已夹闭和未夹闭脑动脉瘤的患者中的安全性;然而,这些患者的动脉瘤破裂率较低(即,≤2.6%),而我们病例中的患者的动脉瘤破裂率为 14.5%。
我们强调,ECT 不应被视为伴有脑动脉瘤患者的普遍安全程序,并且在讨论未夹闭脑动脉瘤患者的 ECT 的风险效益比时,应使用 5 年累积动脉瘤破裂率。